170 related articles for article (PubMed ID: 10854183)
1. Cytokines and cancer immunotherapy.
Wolf SF; Lee K; Swiniarski H; O'Toole M; Sturmhoefel K
Immunol Invest; 2000 May; 29(2):143-6. PubMed ID: 10854183
[No Abstract] [Full Text] [Related]
2. CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?
van Gool SW; Barcy S; Devos S; Vandenberghe P; Ceuppens JL; Thielemans K; de Boer M
Res Immunol; 1995; 146(3):183-96. PubMed ID: 8525052
[No Abstract] [Full Text] [Related]
3. CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.
Linsley PS; Ledbetter J; Peach R; Bajorath J
Res Immunol; 1995; 146(3):130-40. PubMed ID: 8525042
[No Abstract] [Full Text] [Related]
4. The complexities of T-cell co-stimulation: CD28 and beyond.
Sperling AI; Bluestone JA
Immunol Rev; 1996 Oct; 153():155-82. PubMed ID: 9010723
[No Abstract] [Full Text] [Related]
5. Blocking CD28/B7 with soluble competitors: immunological phenotype of mCTLA4-H gamma 1 transgenic mice.
Lane P
Res Immunol; 1995; 146(3):176-9. PubMed ID: 8525050
[No Abstract] [Full Text] [Related]
6. Cattle CTLA-4, CD28 and chicken CD28 bind CD86: MYPPPY is not conserved in cattle CD28.
Parsons KR; Young JR; Collins BA; Howard CJ
Immunogenetics; 1996; 43(6):388-91. PubMed ID: 8606060
[No Abstract] [Full Text] [Related]
7. Treatment of autoimmunity by inhibition of T cell costimulation.
Daikh DI; Wofsy D
Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969
[No Abstract] [Full Text] [Related]
8. New protein steals the show as 'costimulator' of T cells.
Cohen J
Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
[No Abstract] [Full Text] [Related]
9. CTLA-4 and T cell activation.
Oosterwegel MA; Greenwald RJ; Mandelbrot DA; Lorsbach RB; Sharpe AH
Curr Opin Immunol; 1999 Jun; 11(3):294-300. PubMed ID: 10375557
[TBL] [Abstract][Full Text] [Related]
10. Regulation of T and B cell responses by modulating interactions between CD28/CTLA4 and their ligands, CD80 and CD86.
Lane P
Ann N Y Acad Sci; 1997 Apr; 815():392-400. PubMed ID: 9186685
[TBL] [Abstract][Full Text] [Related]
11. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.
Rennert P; Furlong K; Jellis C; Greenfield E; Freeman GJ; Ueda Y; Levine B; June CH; Gray GS
Int Immunol; 1997 Jun; 9(6):805-13. PubMed ID: 9199963
[TBL] [Abstract][Full Text] [Related]
12. Could expression of co-stimulatory molecules on B-PBL condition the acceptance or rejection of human liver grafts?
Minguela A; Sánchez-Bueno F; Marín L; Miras M; Pons JA; Muro M; Torío A; García-Alonso AM; Robles R; Parrilla P; Ramirez P; Alvarez-López MR
Transplant Proc; 2001; 33(1-2):1384-5. PubMed ID: 11267338
[No Abstract] [Full Text] [Related]
13. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.
Metzler WJ; Bajorath J; Fenderson W; Shaw SY; Constantine KL; Naemura J; Leytze G; Peach RJ; Lavoie TB; Mueller L; Linsley PS
Nat Struct Biol; 1997 Jul; 4(7):527-31. PubMed ID: 9228944
[TBL] [Abstract][Full Text] [Related]
15. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.
Schwartz RH
Cell; 1992 Dec; 71(7):1065-8. PubMed ID: 1335362
[No Abstract] [Full Text] [Related]
16. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the costimulatory requirements for generating human virus-specific in vitro T helper and effector responses.
Blazevic V; Trubey CM; Shearer GM
J Clin Immunol; 2001 Jul; 21(4):293-302. PubMed ID: 11506200
[TBL] [Abstract][Full Text] [Related]
18. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
Freeman GJ; Gribben JG; Boussiotis VA; Ng JW; Restivo VA; Lombard LA; Gray GS; Nadler LM
Science; 1993 Nov; 262(5135):909-11. PubMed ID: 7694363
[TBL] [Abstract][Full Text] [Related]
19. CD28 function: a balance of costimulatory and regulatory signals.
Bour-Jordan H; Blueston JA
J Clin Immunol; 2002 Jan; 22(1):1-7. PubMed ID: 11958588
[TBL] [Abstract][Full Text] [Related]
20. The role of B7 costimulation in T-cell immunity.
Harris NL; Ronchese F
Immunol Cell Biol; 1999 Aug; 77(4):304-11. PubMed ID: 10457196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
